EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors

Lina Naseralallah iD, Bodoor Aboujabal iD, Zahra Noureddine iD, Khaled Aboujabal, Somaya Koraysh iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70496 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Lina Naseralallah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, Hamad bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar. Hauptthemen laut MEDLINE: Acidosis, Lactic, Linezolid, Anti-Bacterial Agents. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Linezolid, a synthetic oxazolidinone for resistant gram‐positive infections, is generally associated with mild adverse effects such as gastrointestinal disturbances, but more serious reactions like lactic acidosis (LA) have also been reported. LA may be more pronounced in critically ill patients; therefore, this study aims to determine the incidence, severity and predictors of linezolid‐associated LA in this vulnerable population.

Methods

We conducted a retrospective observational study of adult ICU patients receiving linezolid from January 2021 to May 2025. Data on demographics, comorbidities, linezolid regimen, concomitant medications and laboratory values were collected. Multivariate logistic regression was used to identify predictors of LA.

Results

Of 904 patients screened, 551 were included (mean age 56 years; 73.3% male). LA occurred in 10.7% ( n = 59) and was classified as moderate (22%), severe (49%) or critical (29%), with a mean onset of 4 days. Independent predictors of LA included linezolid at a daily dose of 600 mg (aOR = 50.4; p = 0.028), sepsis (aOR = 2.61; p = 0.042), infections other than pneumonia (aOR = 4.0; p = 0.042) and the use of norepinephrine (aOR = 3.56; p = 0.005).

Conclusion

Linezolid‐associated lactic acidosis is a frequent and often severe complication in ICU patients, typically developing early during therapy. Sepsis, non‐pneumonia infections and norepinephrine use were identified as key risk factors. These findings highlight the need for early recognition and vigilant monitoring of high‐risk patients to promote safer use of linezolid in critically ill populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acidosis, LacticLinezolidAnti-Bacterial AgentsHumansMiddle AgedCritical IllnessRetrospective StudiesFemaleIncidenceMaleAgedSeverity of Illness IndexIntensive Care UnitsRisk FactorsAdult

Stichwörter der Autor:innen

adverse drug reactioncritically ill patientsintensive care unitlactic acidosislinezolidrisk factors

Substanzen

LinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Pharmacy Department, Hamad bin Khalifa Medical City, Hamad Medical Corporation, Doha, Qatar.
  • Pharmacy Department, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
  • Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar.

ORCID-Profile: Lina Naseralallah, Bodoor Aboujabal, Zahra Noureddine, Somaya Koraysh

Zitieren

APA

Naseralallah, L., Aboujabal, B., Noureddine, Z., Aboujabal, K., & Koraysh, S. (2026). Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70496

Vancouver

Naseralallah L, Aboujabal B, Noureddine Z, Aboujabal K, Koraysh S. Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70496

BibTeX
@article{Naseralallah2026,
  author = {Naseralallah, Lina and Aboujabal, Bodoor and Noureddine, Zahra and Aboujabal, Khaled and Koraysh, Somaya},
  title = {Linezolid‐induced lactic acidosis in critically ill patients: A multicentre study of incidence, severity and predictors},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70496}
}
Kostenlos starten →